Annual Net Income:
$4.17B+$2.77B(+197.68%)Summary
- As of April 3, 2025, EW annual net profit is $4.17 billion, with the most recent change of +$2.77 billion (+197.68%) on December 1, 2024.
- During the last 3 years, EW annual net income has risen by +$2.67 billion (+177.73%).
- EW annual net income is now at all-time high.
Performance
EW Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income:
$385.60M-$2.69B(-87.44%)Summary
- As of April 3, 2025, EW quarterly net profit is $385.60 million, with the most recent change of -$2.69 billion (-87.44%) on December 1, 2024.
- Over the past year, EW quarterly net income has stayed the same.
- EW quarterly net income is now -87.44% below its all-time high of $3.07 billion, reached on September 30, 2024.
Performance
EW Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income:
$4.17B+$15.70M(+0.38%)Summary
- As of April 3, 2025, EW TTM net profit is $4.17 billion, with the most recent change of +$15.70 million (+0.38%) on December 1, 2024.
- Over the past year, EW TTM net income has stayed the same.
- EW TTM net income is now at all-time high.
Performance
EW TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
EW Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +197.7% | 0.0% | 0.0% |
| 3 y3 years | +177.7% | 0.0% | 0.0% |
| 5 y5 years | +298.8% | 0.0% | 0.0% |
EW Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +197.7% | -87.4% | +25.6% | at high | +200.4% |
| 5 y | 5-year | at high | +407.0% | -87.4% | +416.3% | at high | +461.4% |
| alltime | all time | at high | +1634.8% | -87.4% | +224.8% | at high | +1529.7% |
Edwards Lifesciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $4.17B(+197.7%) | $385.60M(-87.4%) | $4.17B(+0.4%) |
| Sep 2024 | - | $3.07B(+738.3%) | $4.16B(+182.3%) |
| Jun 2024 | - | $366.30M(+4.1%) | $1.47B(+4.2%) |
| Mar 2024 | - | $351.90M(-4.9%) | $1.41B(+0.8%) |
| Dec 2023 | $1.40B(-7.9%) | $369.90M(-3.9%) | $1.40B(-2.0%) |
| Sep 2023 | - | $384.90M(+25.3%) | $1.43B(+3.0%) |
| Jun 2023 | - | $307.10M(-9.8%) | $1.39B(-6.7%) |
| Mar 2023 | - | $340.50M(-14.5%) | $1.49B(-2.2%) |
| Dec 2022 | $1.52B(+1.3%) | $398.40M(+16.0%) | $1.52B(+4.3%) |
| Sep 2022 | - | $343.50M(-15.5%) | $1.46B(+0.2%) |
| Jun 2022 | - | $406.40M(+8.8%) | $1.46B(-5.4%) |
| Mar 2022 | - | $373.60M(+11.4%) | $1.54B(+2.4%) |
| Dec 2021 | $1.50B(+82.5%) | $335.30M(-1.4%) | $1.50B(+1.7%) |
| Sep 2021 | - | $340.10M(-30.5%) | $1.48B(+1.0%) |
| Jun 2021 | - | $489.50M(+44.7%) | $1.46B(+71.8%) |
| Mar 2021 | - | $338.20M(+9.3%) | $851.00M(+3.4%) |
| Dec 2020 | $823.40M(-21.3%) | $309.50M(-4.8%) | $823.40M(+3.7%) |
| Sep 2020 | - | $325.20M(-366.8%) | $794.10M(+6.8%) |
| Jun 2020 | - | -$121.90M(-139.2%) | $743.60M(-32.9%) |
| Mar 2020 | - | $310.60M(+10.8%) | $1.11B(+5.8%) |
| Dec 2019 | $1.05B(+45.0%) | $280.20M(+2.0%) | $1.05B(+35.3%) |
| Sep 2019 | - | $274.70M(+13.4%) | $773.70M(+6.7%) |
| Jun 2019 | - | $242.30M(-3.0%) | $724.90M(-5.3%) |
| Mar 2019 | - | $249.70M(+3467.1%) | $765.30M(+6.0%) |
| Dec 2018 | $722.20M(+23.7%) | $7.00M(-96.9%) | $722.20M(+1.4%) |
| Sep 2018 | - | $225.90M(-20.1%) | $712.40M(+8.5%) |
| Jun 2018 | - | $282.70M(+36.8%) | $656.60M(+17.3%) |
| Mar 2018 | - | $206.60M(-7478.6%) | $560.00M(-4.0%) |
| Dec 2017 | $583.60M(+2.5%) | -$2.80M(-101.6%) | $583.60M(-21.7%) |
| Sep 2017 | - | $170.10M(-8.6%) | $744.90M(+4.0%) |
| Jun 2017 | - | $186.10M(-19.2%) | $716.20M(+9.1%) |
| Mar 2017 | - | $230.20M(+45.2%) | $656.70M(+15.3%) |
| Dec 2016 | $569.50M(+15.1%) | $158.50M(+12.1%) | $569.50M(+3.2%) |
| Sep 2016 | - | $141.40M(+11.7%) | $551.70M(+4.4%) |
| Jun 2016 | - | $126.60M(-11.5%) | $528.40M(+2.7%) |
| Mar 2016 | - | $143.00M(+1.6%) | $514.50M(+4.0%) |
| Dec 2015 | $494.90M(-39.0%) | $140.70M(+19.1%) | $494.90M(+6.8%) |
| Sep 2015 | - | $118.10M(+4.8%) | $463.40M(+5.3%) |
| Jun 2015 | - | $112.70M(-8.7%) | $439.90M(-49.7%) |
| Mar 2015 | - | $123.40M(+13.0%) | $874.20M(+7.8%) |
| Dec 2014 | $811.10M(+108.5%) | $109.20M(+15.4%) | $811.10M(+4.4%) |
| Sep 2014 | - | $94.60M(-82.7%) | $777.00M(+2.3%) |
| Jun 2014 | - | $547.00M(+807.1%) | $759.20M(+148.5%) |
| Mar 2014 | - | $60.30M(-19.7%) | $305.50M(-21.5%) |
| Dec 2013 | $389.10M(+33.5%) | $75.10M(-2.2%) | $389.10M(-3.5%) |
| Sep 2013 | - | $76.80M(-17.7%) | $403.40M(+1.9%) |
| Jun 2013 | - | $93.30M(-35.2%) | $395.80M(+6.9%) |
| Mar 2013 | - | $143.90M(+61.0%) | $370.30M(+27.0%) |
| Dec 2012 | $291.50M | $89.40M(+29.2%) | $291.50M(+9.9%) |
| Sep 2012 | - | $69.20M(+2.1%) | $265.20M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $67.80M(+4.1%) | $247.60M(+4.1%) |
| Mar 2012 | - | $65.10M(+3.2%) | $237.90M(+0.5%) |
| Dec 2011 | $236.70M(+8.6%) | $63.10M(+22.3%) | $236.70M(-0.7%) |
| Sep 2011 | - | $51.60M(-11.2%) | $238.40M(+1.5%) |
| Jun 2011 | - | $58.10M(-9.1%) | $234.80M(+0.3%) |
| Mar 2011 | - | $63.90M(-1.4%) | $234.20M(+7.4%) |
| Dec 2010 | $218.00M(-4.8%) | $64.80M(+35.0%) | $218.00M(+8.6%) |
| Sep 2010 | - | $48.00M(-16.5%) | $200.80M(-11.3%) |
| Jun 2010 | - | $57.50M(+20.5%) | $226.30M(+4.6%) |
| Mar 2010 | - | $47.70M(+0.2%) | $216.30M(-5.6%) |
| Dec 2009 | $229.10M(+77.7%) | $47.60M(-35.2%) | $229.10M(+4.3%) |
| Sep 2009 | - | $73.50M(+54.7%) | $219.60M(+22.7%) |
| Jun 2009 | - | $47.50M(-21.5%) | $179.00M(+4.6%) |
| Mar 2009 | - | $60.50M(+58.8%) | $171.20M(+32.8%) |
| Dec 2008 | $128.90M(+14.1%) | $38.10M(+15.8%) | $128.90M(+20.9%) |
| Sep 2008 | - | $32.90M(-17.1%) | $106.60M(+3.7%) |
| Jun 2008 | - | $39.70M(+118.1%) | $102.80M(+4.9%) |
| Mar 2008 | - | $18.20M(+15.2%) | $98.00M(-13.3%) |
| Dec 2007 | $113.00M(-13.4%) | $15.80M(-45.7%) | $113.00M(-4.2%) |
| Sep 2007 | - | $29.10M(-16.6%) | $117.90M(+1.1%) |
| Jun 2007 | - | $34.90M(+5.1%) | $116.60M(-1.0%) |
| Mar 2007 | - | $33.20M(+60.4%) | $117.80M(-9.8%) |
| Dec 2006 | $130.50M(+65.2%) | $20.70M(-25.5%) | $130.60M(-11.9%) |
| Sep 2006 | - | $27.80M(-23.0%) | $148.20M(+27.8%) |
| Jun 2006 | - | $36.10M(-21.5%) | $116.00M(+23.7%) |
| Mar 2006 | - | $46.00M(+20.1%) | $93.80M(+18.7%) |
| Dec 2005 | $79.00M(+4547.1%) | $38.30M(-970.5%) | $79.00M(+18.6%) |
| Sep 2005 | - | -$4.40M(-131.7%) | $66.60M(-20.1%) |
| Jun 2005 | - | $13.90M(-55.4%) | $83.40M(-12.2%) |
| Mar 2005 | - | $31.20M(+20.5%) | $95.00M(+5488.2%) |
| Dec 2004 | $1.70M(-97.8%) | $25.90M(+108.9%) | $1.70M(-132.1%) |
| Sep 2004 | - | $12.40M(-51.4%) | -$5.30M(-177.9%) |
| Jun 2004 | - | $25.50M(-141.1%) | $6.80M(+183.3%) |
| Mar 2004 | - | -$62.10M(-428.6%) | $2.40M(-97.0%) |
| Dec 2003 | $79.00M(+41.8%) | $18.90M(-22.9%) | $79.00M(-3.4%) |
| Sep 2003 | - | $24.50M(+16.1%) | $81.80M(+105.0%) |
| Jun 2003 | - | $21.10M(+45.5%) | $39.90M(-19.2%) |
| Mar 2003 | - | $14.50M(-33.2%) | $49.40M(-11.3%) |
| Dec 2002 | $55.70M(-588.6%) | $21.70M(-224.7%) | $55.70M(+9.0%) |
| Sep 2002 | - | -$17.40M(-156.9%) | $51.10M(-38.4%) |
| Jun 2002 | - | $30.60M(+47.1%) | $83.00M(-2615.2%) |
| Mar 2002 | - | $20.80M(+21.6%) | -$3.30M(-71.1%) |
| Dec 2001 | -$11.40M(-95.8%) | $17.10M(+17.9%) | -$11.40M(+208.1%) |
| Sep 2001 | - | $14.50M(-126.0%) | -$3.70M(-73.2%) |
| Jun 2001 | - | -$55.70M(-538.6%) | -$13.80M(-94.8%) |
| Mar 2001 | - | $12.70M(-48.8%) | -$267.10M(+1.6%) |
| Dec 2000 | -$272.00M(-431.7%) | $24.80M(+463.6%) | -$262.80M(-8.6%) |
| Sep 2000 | - | $4.40M(-101.4%) | -$287.60M(-1.5%) |
| Jun 2000 | - | -$309.00M(-1917.6%) | -$292.00M(-1817.6%) |
| Mar 2000 | - | $17.00M | $17.00M |
| Dec 1999 | $82.00M | - | - |
FAQ
- What is Edwards Lifesciences annual net profit?
- What is the all time high annual net income for Edwards Lifesciences?
- What is Edwards Lifesciences annual net income year-on-year change?
- What is Edwards Lifesciences quarterly net profit?
- What is the all time high quarterly net income for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly net income year-on-year change?
- What is Edwards Lifesciences TTM net profit?
- What is the all time high TTM net income for Edwards Lifesciences?
- What is Edwards Lifesciences TTM net income year-on-year change?
What is Edwards Lifesciences annual net profit?
The current annual net income of EW is $4.17B
What is the all time high annual net income for Edwards Lifesciences?
Edwards Lifesciences all-time high annual net profit is $4.17B
What is Edwards Lifesciences annual net income year-on-year change?
Over the past year, EW annual net profit has changed by +$2.77B (+197.68%)
What is Edwards Lifesciences quarterly net profit?
The current quarterly net income of EW is $385.60M
What is the all time high quarterly net income for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly net profit is $3.07B
What is Edwards Lifesciences quarterly net income year-on-year change?
Over the past year, EW quarterly net profit has changed by $0.00 (0.00%)
What is Edwards Lifesciences TTM net profit?
The current TTM net income of EW is $4.17B
What is the all time high TTM net income for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM net profit is $4.17B
What is Edwards Lifesciences TTM net income year-on-year change?
Over the past year, EW TTM net profit has changed by $0.00 (0.00%)